Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 1 to 20 of 91

1.

Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.

Ashraf GM, Greig NH, Khan TA, Hassan I, Tabrez S, Shakil S, Sheikh IA, Zaidi SK, Akram M, Jabir NR, Firoz CK, Naeem A, Alhazza IM, Damanhouri GA, Kamal MA.

CNS Neurol Disord Drug Targets. 2014;13(7):1280-93.

2.

Proteomics approaches to understand linkage between Alzheimer's disease and type 2 diabetes mellitus.

Mirza Z, Ali A, Ashraf GM, Kamal MA, Abuzenadah AM, Choudhary AG, Damanhouri GA, Sheikh IA.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):213-25. Review.

PMID:
24059316
3.

Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases.

Jabir NR, Firoz CK, Baeesa SS, Ashraf GM, Akhtar S, Kamal W, Kamal MA, Tabrez S.

CNS Neurosci Ther. 2015 Jan;21(1):1-7. doi: 10.1111/cns.12344. Epub 2014 Nov 15. Review.

PMID:
25399848
4.

Current challenges to overcome in the management of type 2 diabetes mellitus and associated neurological disorders.

Khan NM, Ahmad A, Tiwari RK, Kamal MA, Mushtaq G, Ashraf GM.

CNS Neurol Disord Drug Targets. 2014;13(8):1440-57.

PMID:
25345504
5.

Recent Updates on the Association Between Alzheimer's Disease and Vascular Dementia.

Ashraf GM, Chibber S, Mohammad, Zaidi SK, Tabrez S, Ahmad A, Shakil S, Mushtaq G, Baeesa SS, Kamal MA.

Med Chem. 2016;12(3):226-37. Review.

PMID:
26527156
6.

Recent Updates on the Dynamic Association Between Oxidative Stress and Neurodegenerative Disorders.

Khan TA, Hassan I, Ahmad A, Perveen A, Aman S, Quddusi S, Alhazza IM, Ashraf GM, Aliev G.

CNS Neurol Disord Drug Targets. 2016;15(3):310-20. Review.

PMID:
26831262
7.

An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy.

Ashraf GM, Tabrez S, Jabir NR, Firoz CK, Ahmad S, Hassan I, Alexiou A, Kamal MA.

Curr Drug Metab. 2015;16(8):719-27. Review.

PMID:
26560324
8.

Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease.

Rizvi SM, Shaikh S, Waseem SM, Shakil S, Abuzenadah AM, Biswas D, Tabrez S, Ashraf GM, Kamal MA.

EXCLI J. 2015 May 19;14:684-96. doi: 10.17179/excli2015-252. eCollection 2015. Review.

9.

Therapeutic Interventions for the Suppression of Alzheimer's Disease: Quest for a Remedy.

Fazili NA, Naeem A, Ashraf GM, Hua GS, Kamal MA.

Curr Drug Metab. 2015;16(5):346-53. Review.

PMID:
25429669
10.

Common Therapeutic Modalities Against Diabetes and Associated Cardiovascular Disease.

Jabir NR, Firoz CK, Ashraf GM, Zaidi SK, Shakil S, Kamal MA, Tabrez S.

Curr Vasc Pharmacol. 2017;15(4):365-373. doi: 10.2174/1570161115666170105125034.

PMID:
28056755
11.

Potential Linkage Between Cerebrovascular Diseases and Metabolic Syndrome.

Jabir NR, Firoz CK, Khan MS, Zaidi SK, Ashraf GM, Shakil S, Kamal MA, Tabrez S.

Curr Drug Metab. 2017;18(1):62-68. doi: 10.2174/1389200217666160810155055.

PMID:
27515564
12.

Reduction of post-prandial hyperglycemia by mulberry tea in type-2 diabetes patients.

Banu S, Jabir NR, Manjunath NC, Khan MS, Ashraf GM, Kamal MA, Tabrez S.

Saudi J Biol Sci. 2015 Jan;22(1):32-6. doi: 10.1016/j.sjbs.2014.04.005. Epub 2014 May 23.

13.

Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders.

Ali A, Sheikh IA, Mirza Z, Gan SH, Kamal MA, Abuzenadah AM, Damanhouri GA, Ashraf GM.

Curr Drug Metab. 2015;16(5):376-88. Review.

PMID:
25495738
14.

Altered galectin glycosylation: potential factor for the diagnostics and therapeutics of various cardiovascular and neurological disorders.

Ashraf GM, Perveen A, Tabrez S, Jabir NR, Damanhouri GA, Zaidi SK, Banu N.

Adv Exp Med Biol. 2015;822:67-84. doi: 10.1007/978-3-319-08927-0_10.

PMID:
25416978
15.

Current Updates on Therapeutic Advances in the Management of Cardiovascular Diseases.

Jabir NR, Siddiqui AN, Firoz CK, Ashraf GM, Zaidi SK, Khan MS, Shakil S, Alama MN, Kamal MA, Tabrez S.

Curr Pharm Des. 2016;22(5):566-71. Review.

PMID:
26601967
16.

Nanotechnology-based approaches in anticancer research.

Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA.

Int J Nanomedicine. 2012;7:4391-408. doi: 10.2147/IJN.S33838. Epub 2012 Aug 9. Review.

17.

Integrating Qualitative and Quantitative Tools for the Detection and Identification of Lectins in Major Human Diseases.

Ashraf GM, Perveen A, Zaidi SK, Tabrez S, Shakil S, Ahmad A, Haque R, Ahsan J, Kamal MA, Banu N.

Protein Pept Lett. 2015;22(11):954-62. Review.

PMID:
26419242
18.

Linkage of Stress with Neuromuscular Disorders.

Ashraf GM, Ali A, Tabrez S, Zaidi SK, Shakil S, Alam MZ, Rehan M, Aliev G.

CNS Neurol Disord Drug Targets. 2016;15(3):321-8. Review.

PMID:
26831261
19.

A putative association of interleukin-10 promoter polymorphisms with cardiovascular disease.

Tabrez S, Ali M, Jabir NR, Firoz CK, Ashraf GM, Hindawi S, Damanhouri GA, Nabil Alama M.

IUBMB Life. 2017 Jul;69(7):522-527. doi: 10.1002/iub.1637. Epub 2017 May 5.

PMID:
28474494
20.

Galectins-A Potential Target for Cardiovascular Therapy.

Ashraf GM, Perveen A, Zaidi SK, Ahmad A, Shakil S, Firoz CK, Jabir NR, Hassan I, Khan TA, Yarla NS, Tabrez S.

Curr Vasc Pharmacol. 2017;15(4):296-312. doi: 10.2174/1570161115666170201113046.

PMID:
28155611

Supplemental Content

Support Center